Systemic Idiopathic Juvenile Arthritis Treatment Market, Global Outlook and Forecast 2022-2028

Systemic Idiopathic Juvenile Arthritis Treatment Market, Global Outlook and Forecast 2022-2028

Report Code: KNJ1281638 | No. of Pages: 63 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2022
This report contains market size and forecasts of Systemic Idiopathic Juvenile Arthritis Treatment in Global, including the following market information:
Global Systemic Idiopathic Juvenile Arthritis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Systemic Idiopathic Juvenile Arthritis Treatment market was valued at  million in 2021 and is projected to reach US$  million by 2028, at a CAGR of  % during the forecast period.
The U.S. Market is Estimated at $  Million in 2021, While China is Forecast to Reach $  Million by 2028.
Adalimumab Biosimilar Segment to Reach $  Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Systemic Idiopathic Juvenile Arthritis Treatment include Alteogen Inc., Bristol-Myers Squibb Company, Epirus Biopharmaceuticals, Inc., Johnson & Johnson, Momenta Pharmaceuticals, Inc., Mycenax Biotech Inc., Novartis AG and Oncobiologics, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Systemic Idiopathic Juvenile Arthritis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Systemic Idiopathic Juvenile Arthritis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Systemic Idiopathic Juvenile Arthritis Treatment Market Segment Percentages, by Type, 2021 (%)
    Adalimumab Biosimilar
    Canakinumab
    Golimumab
    Tocilizumab Biosimilar
    Others
Global Systemic Idiopathic Juvenile Arthritis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Systemic Idiopathic Juvenile Arthritis Treatment Market Segment Percentages, by Application, 2021 (%)
    Clinic
    Hospital
    Others
Global Systemic Idiopathic Juvenile Arthritis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Systemic Idiopathic Juvenile Arthritis Treatment Market Segment Percentages, By Region and Country, 2021 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Systemic Idiopathic Juvenile Arthritis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Systemic Idiopathic Juvenile Arthritis Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Alteogen Inc.
    Bristol-Myers Squibb Company
    Epirus Biopharmaceuticals, Inc.
    Johnson & Johnson
    Momenta Pharmaceuticals, Inc.
    Mycenax Biotech Inc.
    Novartis AG
    Oncobiologics, Inc.
1 Introduction to Research & Analysis Reports
    1.1 Systemic Idiopathic Juvenile Arthritis Treatment Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Systemic Idiopathic Juvenile Arthritis Treatment Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Systemic Idiopathic Juvenile Arthritis Treatment Overall Market Size
    2.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Market Size: 2021 VS 2028
    2.2 Global Systemic Idiopathic Juvenile Arthritis Treatment Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Systemic Idiopathic Juvenile Arthritis Treatment Players in Global Market
    3.2 Top Global Systemic Idiopathic Juvenile Arthritis Treatment Companies Ranked by Revenue
    3.3 Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue by Companies
    3.4 Top 3 and Top 5 Systemic Idiopathic Juvenile Arthritis Treatment Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Systemic Idiopathic Juvenile Arthritis Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Systemic Idiopathic Juvenile Arthritis Treatment Players in Global Market
        3.6.1 List of Global Tier 1 Systemic Idiopathic Juvenile Arthritis Treatment Companies
        3.6.2 List of Global Tier 2 and Tier 3 Systemic Idiopathic Juvenile Arthritis Treatment Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Systemic Idiopathic Juvenile Arthritis Treatment Market Size Markets, 2021 & 2028
        4.1.2 Adalimumab Biosimilar
        4.1.3 Canakinumab
        4.1.4 Golimumab
        4.1.5 Tocilizumab Biosimilar
        4.1.6 Others
    4.2 By Type - Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue & Forecasts
        4.2.1 By Type - Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue, 2017-2022
        4.2.2 By Type - Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue, 2023-2028
        4.2.3 By Type - Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Systemic Idiopathic Juvenile Arthritis Treatment Market Size, 2021 & 2028
        5.1.2 Clinic
        5.1.3 Hospital
        5.1.4 Others
    5.2 By Application - Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue & Forecasts
        5.2.1 By Application - Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue, 2017-2022
        5.2.2 By Application - Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue, 2023-2028
        5.2.3 By Application - Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Systemic Idiopathic Juvenile Arthritis Treatment Market Size, 2021 & 2028
    6.2 By Region - Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue & Forecasts
        6.2.1 By Region - Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue, 2017-2022
        6.2.2 By Region - Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue, 2023-2028
        6.2.3 By Region - Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Systemic Idiopathic Juvenile Arthritis Treatment Revenue, 2017-2028
        6.3.2 US Systemic Idiopathic Juvenile Arthritis Treatment Market Size, 2017-2028
        6.3.3 Canada Systemic Idiopathic Juvenile Arthritis Treatment Market Size, 2017-2028
        6.3.4 Mexico Systemic Idiopathic Juvenile Arthritis Treatment Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Systemic Idiopathic Juvenile Arthritis Treatment Revenue, 2017-2028
        6.4.2 Germany Systemic Idiopathic Juvenile Arthritis Treatment Market Size, 2017-2028
        6.4.3 France Systemic Idiopathic Juvenile Arthritis Treatment Market Size, 2017-2028
        6.4.4 U.K. Systemic Idiopathic Juvenile Arthritis Treatment Market Size, 2017-2028
        6.4.5 Italy Systemic Idiopathic Juvenile Arthritis Treatment Market Size, 2017-2028
        6.4.6 Russia Systemic Idiopathic Juvenile Arthritis Treatment Market Size, 2017-2028
        6.4.7 Nordic Countries Systemic Idiopathic Juvenile Arthritis Treatment Market Size, 2017-2028
        6.4.8 Benelux Systemic Idiopathic Juvenile Arthritis Treatment Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Systemic Idiopathic Juvenile Arthritis Treatment Revenue, 2017-2028
        6.5.2 China Systemic Idiopathic Juvenile Arthritis Treatment Market Size, 2017-2028
        6.5.3 Japan Systemic Idiopathic Juvenile Arthritis Treatment Market Size, 2017-2028
        6.5.4 South Korea Systemic Idiopathic Juvenile Arthritis Treatment Market Size, 2017-2028
        6.5.5 Southeast Asia Systemic Idiopathic Juvenile Arthritis Treatment Market Size, 2017-2028
        6.5.6 India Systemic Idiopathic Juvenile Arthritis Treatment Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Systemic Idiopathic Juvenile Arthritis Treatment Revenue, 2017-2028
        6.6.2 Brazil Systemic Idiopathic Juvenile Arthritis Treatment Market Size, 2017-2028
        6.6.3 Argentina Systemic Idiopathic Juvenile Arthritis Treatment Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Revenue, 2017-2028
        6.7.2 Turkey Systemic Idiopathic Juvenile Arthritis Treatment Market Size, 2017-2028
        6.7.3 Israel Systemic Idiopathic Juvenile Arthritis Treatment Market Size, 2017-2028
        6.7.4 Saudi Arabia Systemic Idiopathic Juvenile Arthritis Treatment Market Size, 2017-2028
        6.7.5 UAE Systemic Idiopathic Juvenile Arthritis Treatment Market Size, 2017-2028
7 Players Profiles
    7.1 Alteogen Inc.
        7.1.1 Alteogen Inc. Corporate Summary
        7.1.2 Alteogen Inc. Business Overview
        7.1.3 Alteogen Inc. Systemic Idiopathic Juvenile Arthritis Treatment Major Product Offerings
        7.1.4 Alteogen Inc. Systemic Idiopathic Juvenile Arthritis Treatment Revenue in Global Market (2017-2022)
        7.1.5 Alteogen Inc. Key News
    7.2 Bristol-Myers Squibb Company
        7.2.1 Bristol-Myers Squibb Company Corporate Summary
        7.2.2 Bristol-Myers Squibb Company Business Overview
        7.2.3 Bristol-Myers Squibb Company Systemic Idiopathic Juvenile Arthritis Treatment Major Product Offerings
        7.2.4 Bristol-Myers Squibb Company Systemic Idiopathic Juvenile Arthritis Treatment Revenue in Global Market (2017-2022)
        7.2.5 Bristol-Myers Squibb Company Key News
    7.3 Epirus Biopharmaceuticals, Inc.
        7.3.1 Epirus Biopharmaceuticals, Inc. Corporate Summary
        7.3.2 Epirus Biopharmaceuticals, Inc. Business Overview
        7.3.3 Epirus Biopharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Major Product Offerings
        7.3.4 Epirus Biopharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Revenue in Global Market (2017-2022)
        7.3.5 Epirus Biopharmaceuticals, Inc. Key News
    7.4 Johnson & Johnson
        7.4.1 Johnson & Johnson Corporate Summary
        7.4.2 Johnson & Johnson Business Overview
        7.4.3 Johnson & Johnson Systemic Idiopathic Juvenile Arthritis Treatment Major Product Offerings
        7.4.4 Johnson & Johnson Systemic Idiopathic Juvenile Arthritis Treatment Revenue in Global Market (2017-2022)
        7.4.5 Johnson & Johnson Key News
    7.5 Momenta Pharmaceuticals, Inc.
        7.5.1 Momenta Pharmaceuticals, Inc. Corporate Summary
        7.5.2 Momenta Pharmaceuticals, Inc. Business Overview
        7.5.3 Momenta Pharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Major Product Offerings
        7.5.4 Momenta Pharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Revenue in Global Market (2017-2022)
        7.5.5 Momenta Pharmaceuticals, Inc. Key News
    7.6 Mycenax Biotech Inc.
        7.6.1 Mycenax Biotech Inc. Corporate Summary
        7.6.2 Mycenax Biotech Inc. Business Overview
        7.6.3 Mycenax Biotech Inc. Systemic Idiopathic Juvenile Arthritis Treatment Major Product Offerings
        7.6.4 Mycenax Biotech Inc. Systemic Idiopathic Juvenile Arthritis Treatment Revenue in Global Market (2017-2022)
        7.6.5 Mycenax Biotech Inc. Key News
    7.7 Novartis AG
        7.7.1 Novartis AG Corporate Summary
        7.7.2 Novartis AG Business Overview
        7.7.3 Novartis AG Systemic Idiopathic Juvenile Arthritis Treatment Major Product Offerings
        7.7.4 Novartis AG Systemic Idiopathic Juvenile Arthritis Treatment Revenue in Global Market (2017-2022)
        7.7.5 Novartis AG Key News
    7.8 Oncobiologics, Inc.
        7.8.1 Oncobiologics, Inc. Corporate Summary
        7.8.2 Oncobiologics, Inc. Business Overview
        7.8.3 Oncobiologics, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Major Product Offerings
        7.8.4 Oncobiologics, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Revenue in Global Market (2017-2022)
        7.8.5 Oncobiologics, Inc. Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com